UK markets closed

Tandem Diabetes Care, Inc. (0M0F.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
44.41+3.38 (+8.24%)
At close: 02:41PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3N/A
S&P500 52-week change 3-7.75%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 557.37M
Implied shares outstanding 6N/A
Float 863.79M
% held by insiders 10.52%
% held by institutions 1101.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022


Profit margin -8.59%
Operating margin (ttm)-3.96%

Management effectiveness

Return on assets (ttm)-2.06%
Return on equity (ttm)-16.74%

Income statement

Revenue (ttm)790.71M
Revenue per share (ttm)12.36
Quarterly revenue growth (yoy)13.90%
Gross profit (ttm)376.21M
EBITDA -17.11M
Net income avi to common (ttm)-67.93M
Diluted EPS (ttm)0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)608.73M
Total cash per share (mrq)9.47
Total debt (mrq)422.02M
Total debt/equity (mrq)100.05
Current ratio (mrq)4.80
Book value per share (mrq)6.56

Cash flow statement

Operating cash flow (ttm)64.28M
Levered free cash flow (ttm)12.63M